MASM
GILD icon

MH & Associates Securities Management’s Gilead Sciences GILD Stock Holding History

MH & Associates Securities Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.31M Sell
26,161
-103
-0.4% -$13.6K 2.96% 13
2026
Q1 		$3.66M Sell
26,264
-10,998
-30% -$1.54M 3.19% 9
2025
Q4 		$4.57M Buy
+37,262
New +$4.53M 3.73% 3

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return

MH & Associates Securities Management's GILD Position: Q2 2026 in Review

MH & Associates Securities Management reduced its Gilead Sciences (GILD) stake by 0.39% in Q2 2026, selling an estimated $13.6K and leaving 26,161 shares worth $3.31M. The position accounts for 2.96% of the portfolio, ranked #13.

MH & Associates Securities Management first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.57M in Q4 2025. 1,576 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • MH & Associates Securities Management held 26,161 shares of Gilead Sciences worth $3.31M as of Q2 2026.
  • MH & Associates Securities Management sold 103 Gilead Sciences shares in Q2 2026, an estimated $13.6K.
  • Gilead Sciences made up 2.96% of MH & Associates Securities Management's portfolio in Q2 2026, its #13 holding.
  • MH & Associates Securities Management first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • MH & Associates Securities Management's Gilead Sciences position peaked at $4.57M in Q4 2025.
  • 1,576 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on MH & Associates Securities Management's 13F filing for Q2 2026, filed 28 Jul 2026.